Overview
Pyquvi is a corticosteroid medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD) in people 5 years of age and older. Pyquvi is also known by its…

Overview
Viltepso is approved by the U.S. Food and Drug Administration (FDA) under accelerated approval for treating Duchenne muscular dystrophy (DMD) in people with a specific mutation (variation) in the DMD gene that is…

Overview
Vyondys 53, approved by the U.S. Food and Drug Administration (FDA), is used to treat Duchenne muscular dystrophy (DMD) in people with a confirmed mutation (variation) of the DMD gene that allows for exon 53…